GLP-1 therapies, or glucagon-like peptide-1 receptor agonists , represent a substantial innovation in how we treat type 2 diabetes . These injectable drugs function to stimulating the body’s inherent https://ilovebookmarking.com/story21735648/glp-1-a-revolutionary-breakthrough-in-glucose-treatment